|   HOME   |   SITEMAP   |   CONTACT    
About us
Breslin AG
   Private Equity

   Secondary Investments

   Life Sciences

   Corporate Development

   Corporate Finance

Breslin Biotech AG

Corporate Finance

Since 1996, Breslin has identified and qualified buyers and sellers, ultimately bringing them together for successful transactions. As a part of the preparation for acquisition, Breslin assists companies to identify strategic objectives, identify potential targets, develop the strategic planning of acquisitions, provide valuation of the company and negotiate heads of agreement and execution of the transaction. Breslin also has the expertise and contacts to assist in leveraging financing for the transaction. In recent years Breslin has an impressive record organizing pure mergers and acquisitions totaling in excess of €250m.

Private and Pre-IPO Placements
On average there is a 50% increase in valuation for a company going IPO. Breslin assists a company’s readiness for an IPO, provides advice and assistance on fundraising possibilities and shareholder structures and assists on all aspects of the floatation process. Having been successful in taking 19 companies to IPO, Breslin is ideally suited to provide companies advice for an anticipated IPO. Breslin’s advice is based on its insight into capital markets and experience of its prominent financial advisors.

Exit Management
Exit situations require strong management, tactical positioning and a global network to secure a desirable partner. Breslin understands the value of technology and assets. Through expertise and a global network of financial and life science companies, Breslin is well positioned to assist management wishing to divest from business in an efficient manner. Having managed over 50 exits, Breslin has a track record of providing solid exit management strategies for clients.

Corporate restructuring and business turnaround can be complex. Effective execution requires sound management, experience, appreciation and prioritization of the issues. Breslin’s highly experienced advisors are accustomed to devising creative and assertive solutions for corporate restructuring and business turnaround. Breslin’s understanding of commercial issues stems from more than 80 years of operational management experience and more than 50 board positions covering the Life Science, Technology and Financial Industries. Breslin’s focus for restructuring and turnaround is to increase revenue, decrease expenses and strengthen management controls.

Breslin works with members of Management wishing to buy out or buy in a company or its assets. Broad commercial brokerage experience and access to vendors enable Breslin to secure funds necessary for a transaction, including the selection, introduction and negotiation with potentially interested investment parties. Breslin ensures leading advisory services to the management team throughout the transaction from inception to legal completion.

© Breslin AG; webdesign by firegroup